Cargando…
Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT
Background: 68Ga-PSMA-11 PET/CT is a promising method for the assessment of local recurrence (LR) in prostate cancer (PCa) patients. The aim of this study was to evaluate the diagnostic performance of early 68Ga-PSMA-11 PET imaging in comparison to 68Ga-PSMA-11 PET imaging 60 min post-injection (p.i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304119/ https://www.ncbi.nlm.nih.gov/pubmed/34208989 http://dx.doi.org/10.3390/diagnostics11071191 |
_version_ | 1783727256756027392 |
---|---|
author | Bayerschmidt, Steffen Uprimny, Christian Kroiss, Alexander Stephan Fritz, Josef Nilica, Bernhard Svirydenka, Hanna Decristoforo, Clemens von Guggenberg, Elisabeth Horninger, Wolfgang Virgolini, Irene Johanna |
author_facet | Bayerschmidt, Steffen Uprimny, Christian Kroiss, Alexander Stephan Fritz, Josef Nilica, Bernhard Svirydenka, Hanna Decristoforo, Clemens von Guggenberg, Elisabeth Horninger, Wolfgang Virgolini, Irene Johanna |
author_sort | Bayerschmidt, Steffen |
collection | PubMed |
description | Background: 68Ga-PSMA-11 PET/CT is a promising method for the assessment of local recurrence (LR) in prostate cancer (PCa) patients. The aim of this study was to evaluate the diagnostic performance of early 68Ga-PSMA-11 PET imaging in comparison to 68Ga-PSMA-11 PET imaging 60 min post-injection (p.i.) in the detection of LR in patients with biochemical recurrence (BR) of prostate carcinoma. Materials and Methods: 190 image sets of patients with BR in PCa who underwent 68Ga-PSMA-11 PET/CT were assessed retrospectively (median prostate specific antigen (PSA) value, 0.70 ng/mL (range, 0.1–105.6 ng/mL)). Patients received an early static scan of the pelvic area (median, 248 s p.i. (range, 56–923 s)) and a whole-body scan 60 min p.i. (median, 64 min p.i. (range, 45–100 min)) with intravenous administration of 20 mg furosemide i.v. at the time of tracer application, followed by intravenous hydration with 500 mL of sodium chloride (NaCl 0.9%). Assessment was based on visual analysis and calculation of the maximum standardized uptake value (SUVmax) of the pathologic lesions present in the prostate fossa found in the early PET imaging and 60 min PET scans. The scans were characterized as negative, positive, or equivocal. The results were compared, and the combination of early and 60 min p.i. imaging was evaluated. Results: Image assessment resulted in 30 (15.8%) positive, 17 (8.9%) equivocal, and 143 (75.3%) negative findings in early scans, and 28 (14.7%) positive, 25 (13.2%) equivocal, and 137 (72.1%) negative findings of LR in 60 min p.i. images. For combined image analysis, 33 (17.4%) cases were positive and 20 (10.5%) were equivocal. There was no statistical significance between the number of positive (p = 0.815), negative (p = 0.327), and equivocal (p = 0.152) findings. Furthermore, the combination of both scans showed no statistically significant differences for the positive and negative findings (p = 0.063). The median SUVmax was 4.9 (range, 2.0–55.2) for positive lesions in the early scans and 8.0 (range, 2.1–139.9) in the scans 60 min p.i. The median SUVmax for bladder activity was 2.5 (range, 0.9–12.2) in the early scans and 8.2 (range, 1.8–27.6) in the scans 60 min p.i. Conclusion: Early static imaging additional to 68Ga-PSMA-11 PET images acquired 60 min p.i. has limited value in patients prepared with furosemide and hydration, and showed no statistically significant change in the detection rate (DR) of LR and the number of equivocal findings. Based on our results, in departments following a protocol with forced diuresis, including furosemide, additional early static imaging cannot be routinely recommended for the assessment of BR in PCa patients. |
format | Online Article Text |
id | pubmed-8304119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83041192021-07-25 Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT Bayerschmidt, Steffen Uprimny, Christian Kroiss, Alexander Stephan Fritz, Josef Nilica, Bernhard Svirydenka, Hanna Decristoforo, Clemens von Guggenberg, Elisabeth Horninger, Wolfgang Virgolini, Irene Johanna Diagnostics (Basel) Article Background: 68Ga-PSMA-11 PET/CT is a promising method for the assessment of local recurrence (LR) in prostate cancer (PCa) patients. The aim of this study was to evaluate the diagnostic performance of early 68Ga-PSMA-11 PET imaging in comparison to 68Ga-PSMA-11 PET imaging 60 min post-injection (p.i.) in the detection of LR in patients with biochemical recurrence (BR) of prostate carcinoma. Materials and Methods: 190 image sets of patients with BR in PCa who underwent 68Ga-PSMA-11 PET/CT were assessed retrospectively (median prostate specific antigen (PSA) value, 0.70 ng/mL (range, 0.1–105.6 ng/mL)). Patients received an early static scan of the pelvic area (median, 248 s p.i. (range, 56–923 s)) and a whole-body scan 60 min p.i. (median, 64 min p.i. (range, 45–100 min)) with intravenous administration of 20 mg furosemide i.v. at the time of tracer application, followed by intravenous hydration with 500 mL of sodium chloride (NaCl 0.9%). Assessment was based on visual analysis and calculation of the maximum standardized uptake value (SUVmax) of the pathologic lesions present in the prostate fossa found in the early PET imaging and 60 min PET scans. The scans were characterized as negative, positive, or equivocal. The results were compared, and the combination of early and 60 min p.i. imaging was evaluated. Results: Image assessment resulted in 30 (15.8%) positive, 17 (8.9%) equivocal, and 143 (75.3%) negative findings in early scans, and 28 (14.7%) positive, 25 (13.2%) equivocal, and 137 (72.1%) negative findings of LR in 60 min p.i. images. For combined image analysis, 33 (17.4%) cases were positive and 20 (10.5%) were equivocal. There was no statistical significance between the number of positive (p = 0.815), negative (p = 0.327), and equivocal (p = 0.152) findings. Furthermore, the combination of both scans showed no statistically significant differences for the positive and negative findings (p = 0.063). The median SUVmax was 4.9 (range, 2.0–55.2) for positive lesions in the early scans and 8.0 (range, 2.1–139.9) in the scans 60 min p.i. The median SUVmax for bladder activity was 2.5 (range, 0.9–12.2) in the early scans and 8.2 (range, 1.8–27.6) in the scans 60 min p.i. Conclusion: Early static imaging additional to 68Ga-PSMA-11 PET images acquired 60 min p.i. has limited value in patients prepared with furosemide and hydration, and showed no statistically significant change in the detection rate (DR) of LR and the number of equivocal findings. Based on our results, in departments following a protocol with forced diuresis, including furosemide, additional early static imaging cannot be routinely recommended for the assessment of BR in PCa patients. MDPI 2021-06-30 /pmc/articles/PMC8304119/ /pubmed/34208989 http://dx.doi.org/10.3390/diagnostics11071191 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bayerschmidt, Steffen Uprimny, Christian Kroiss, Alexander Stephan Fritz, Josef Nilica, Bernhard Svirydenka, Hanna Decristoforo, Clemens von Guggenberg, Elisabeth Horninger, Wolfgang Virgolini, Irene Johanna Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT |
title | Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT |
title_full | Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT |
title_fullStr | Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT |
title_full_unstemmed | Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT |
title_short | Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT |
title_sort | comparison of early imaging and imaging 60 min post-injection after forced diuresis with furosemide in the assessment of local recurrence in prostate cancer patients with biochemical recurrence referred for 68ga-psma-11 pet/ct |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304119/ https://www.ncbi.nlm.nih.gov/pubmed/34208989 http://dx.doi.org/10.3390/diagnostics11071191 |
work_keys_str_mv | AT bayerschmidtsteffen comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct AT uprimnychristian comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct AT kroissalexanderstephan comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct AT fritzjosef comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct AT nilicabernhard comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct AT svirydenkahanna comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct AT decristoforoclemens comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct AT vonguggenbergelisabeth comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct AT horningerwolfgang comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct AT virgoliniirenejohanna comparisonofearlyimagingandimaging60minpostinjectionafterforceddiuresiswithfurosemideintheassessmentoflocalrecurrenceinprostatecancerpatientswithbiochemicalrecurrencereferredfor68gapsma11petct |